Arcline Investment Management Acquires Polypeptide Therapeutic Solutions (PTS)

April 27, 2021

Arcline Investment Management, a growth-oriented private equity firm, has acquired Polypeptide Therapeutic Solutions, S.L. (PTS) from Columbus Venture Partners. PTS is a Valencia-based GMP CDMO specializing in polyamino-acid (PAA) nanoparticle encapsulation and related drug-delivery services; Arcline plans to scale GMP production and expand the company's technology portfolio to support mRNA, gene/cell therapies, biologics and vaccines.

Buyers
Arcline Investment Management
Targets
Polypeptide Therapeutic Solutions, S.L. (PTS)
Sellers
Columbus Venture Partners
Industry
Biotechnology
Location
Valencian Community, Spain
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.